Contribution of cytochrome P450 2D6 to 3,4-methylenedioxymethamphetamine disposition in humans: Use of paroxetine as a metabolic inhibitor probe

  1. Segura, M.
  2. Farré, M.
  3. Pichini, S.
  4. Peiró, A.M.
  5. Roset, P.N.
  6. Ramírez, A.
  7. Ortuño, J.
  8. Pacifici, R.
  9. Zuccaro, P.
  10. Segura, J.
  11. De La Torre, R.
Journal:
Clinical Pharmacokinetics

ISSN: 0312-5963 0312-5963

Year of publication: 2005

Volume: 44

Issue: 6

Pages: 649-660

Type: Article

DOI: 10.2165/00003088-200544060-00006 GOOGLE SCHOLAR

Sustainable development goals